Clarkston Consulting
Skip to content

Top Life Sciences Insights from 2022 

As 2022 comes to a close, I’ve taken time to reflect on the 200+ content pieces that our industry experts here at Clarkston have generated over the past year. Below, I’ve highlighted just a few of our top insights for life sciences in 2022. For all of our 2022 life sciences insights, you can read more here. 

Top 8: 2022 Life Sciences Insights 

1. Cell and Gene Therapy Product Documents to Drive Decision-Making  

The processes and platforms in place for a pre-clinical startup look a lot different than a mature, commercialized company. While working with a start-up cell and gene therapy (CGT) company can be exciting, figuring out new processes, platforms, and procedures – in addition to making critical decisions for growth – can be challenging and overwhelming. How do you stay focused and ensure alignment while working toward a goal? In this piece, Linda Plumley, director, explains product documents that can help to drive decision-making and tips for enhancing operational success.   

Read About Product Documents for CGT

2. Patient Centricity Assessment and Strategy  

When life sciences companies are trying to become more patient-centric organizations, there needs to be a clear, consistent vision of how to achieve that. This includes identifying any current barriers, getting executive leadership on board, and defining a strategy and roadmap to move your organization along the Patient Centricity Maturity Model. In this case study, Aaron Chio, associate partner, and Amy Levine, director, walk us through a patient centricity assessment for a global generic pharmaceutical company.  

Read the Case Study


3. Managing Custom Raw Materials for mRNA Production 

First discovered in the 1960s and brought into the spotlight during the COVID-19 pandemic, mRNA has the potential to be the future of medicine. Many of the materials used to manufacture and deliver mRNA, however, are custom, which poses a number of challenges for the development and production of final products. In this piece, Swati Patel, director, and Michael Lanewala, manager, discuss custom raw materials in and mitigation strategies for mRNA production.  

Explore mRNA Production


4. UX/UI Best Practices for Disease Awareness Websites

Disease awareness sites and patient portals provide patients and caregivers with a platform to both educate themselves and connect with their healthcare providers. As life sciences companies build out these websites, however, they need to be mindful to keep the patient at the center of it all to ensure a good user experience (UX). Doing so enables patients to feel empowered, educated, and engaged with their own health journey. In this piece, Sara Morris, senior visual branding, communications, and UI/UX design consultant, explores UX/UI best practices to make sure your disease awareness website is accessible, informative, and patient-centered. 

Discover Best Practices for Disease Awareness Websites


5. Capability Building for Emerging Commercial Biotech Companies  

The path from start-up to commercial can be challenging in biotech– it takes significant time, resources, and investments to successfully navigate a product launch. In order to achieve commercial success, start-up biotech companies need to carefully plan and fund their infrastructure projects and establish business capabilities. In this piece, Swati Patel, director, explains how companies can use capability building to manage enterprise-wide projects, optimize results, and enhance operational efficiency.  

Read About Capability Building


6. Taking a Look at the Impact of 5G in Healthcare  

The introduction of 5G – the latest generation of wireless networks – into the healthcare industry has the potential to make a significant impact on healthcare providers, pharmaceutical companies, and patients. From reliable connections for telehealth visits, to exciting advancements in medical technology, to secure access to healthcare data, 5G is a technological gamechanger for healthcare. In this piece, Allyson Hein, project manager and medical device industry lead, outlines 5G capabilities and the advantages it brings to the industry.   

Read About 5G in Healthcare


7. Scientific Data Management System (SDMS) For Laboratory Operations 

Most life sciences companies are continuing to innovate and build toward a “lab of the future,” but they must keep compliance in mind, particularly when it comes to storing and managing raw data. Even with utilizing LIMS, compliance issues might arise when reprocessing data, transferring files, or changing data, all of which have serious implications for affecting data integrity. In this piece, George Adams, senior manager and quality management and systems expert, talks through the benefits of implementing an SDMS for your laboratory operations. 

Explore the Benefits of SDMS


8. Key Considerations for a LIMS Vendor Selection 

In an increasingly competitive and evolving laboratory space, Laboratory Information Management System (LIMS) software can provide your lab operations with considerable benefits, from improved productivity to increased profitability. But first, you need to find the right LIMS that meets your business needs and long-term initiatives. Where do you start? In this piece, LaToya Lee Jones, associate partner, provides key considerations for evaluating and selecting a LIMS vendor and the value of partnering with outside, unbiased LIMS experts to help with that process.   

Read LIMS Vendor Selection Considerations


Subscribe to Clarkston's Insights

  • I'm interested in...
  • Clarkston Consulting requests your information to share our research and content with you.

    You may unsubscribe from these communications at any time.

  • This field is for validation purposes and should be left unchanged.
Tags: Life Sciences Trends